6月4款創新藥有望被FDA批准|Bilingual
us/press-release/newly-published-results-showed-spesolimab-significantly-improved-signs-and-symptoms[3] Amylyx Pharmaceu...
us/press-release/newly-published-results-showed-spesolimab-significantly-improved-signs-and-symptoms[3] Amylyx Pharmaceu...
▎藥明康德內容團隊編輯明日,美國FDA將召集外部專家委員會,討論Amylyx公司在研療法AMX0035治療肌萎縮側索硬化(ALS)患者的臨床試驗資料,是否支援它獲得監管批准上市...